or Try an Advanced Search...

    Technical Analysis for COEP - Coeptis Therapeutics Holdings, Inc

    Grade Last Price % Change Price Change
    F 0.33 3.98% 0.01
    COEP closed up 3.98 percent on Friday, April 26, 2024, on 18 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical COEP trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish 3.98%
    NR7 Range Contraction 3.98%
    Narrow Range Bar Range Contraction 3.98%
    Doji - Bullish? Reversal 3.98%
    Wide Bands Range Expansion 3.98%
    Down 3 Days in a Row Weakness 3.98%
    Oversold Stochastic Weakness 3.98%
    Older End-of-Day Signals for COEP ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 12 hours ago
    Gap Up Closed about 13 hours ago
    Gapped Up (Full) about 14 hours ago
    Rose Above Previous Day's High about 14 hours ago
    10 DMA Resistance about 14 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    COEP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Cell Therapy

    Is COEP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 2 Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research Award
    Feb 26 Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK
    Feb 7 Coeptis Therapeutics to Pursue Phase 2 Program Using Proprietary First-in-Class Allogeneic NK Cell Therapy for the Treatment of Viral Infections
    Jan 18 Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying
    Jan 4 Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024
    Dec 5 Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now
    Dec 4 Coeptis Therapeutics to Present at the Emerging Growth Conference
    Oct 31 Coeptis Therapeutics Announces Research Demonstrating the Potential of SNAP-CAR T-cells to Reduce Tumor Burden and Growth in HER2 and CD20 Expressing Cancers Will be Presented at SITC 2023
    Oct 24 Coeptis Therapeutics to raise $2M in a private placement
    Oct 24 Coeptis Therapeutics Announces $2 Million Private Placement
    See more COEP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.1899
    52 Week Low 0.2851
    Average Volume 291,790
    200-Day Moving Average 0.85
    50-Day Moving Average 0.40
    20-Day Moving Average 0.35
    10-Day Moving Average 0.35
    Average True Range 0.04
    RSI (14) 43.82
    ADX 16.22
    +DI 19.20
    -DI 19.20
    Chandelier Exit (Long, 3 ATRs) 0.36
    Chandelier Exit (Short, 3 ATRs) 0.41
    Upper Bollinger Bands 0.42
    Lower Bollinger Band 0.28
    Percent B (%b) 0.38
    BandWidth 39.49
    MACD Line -0.02
    MACD Signal Line -0.02
    MACD Histogram -0.0001
    Fundamentals Value
    Market Cap 11.42 Million
    Num Shares 34.1 Million
    EPS -0.61
    Price-to-Earnings (P/E) Ratio -0.55
    Price-to-Sales 45.68
    Price-to-Book 3.27
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.38
    Resistance 3 (R3) 0.38 0.36 0.37
    Resistance 2 (R2) 0.36 0.35 0.36 0.37
    Resistance 1 (R1) 0.35 0.35 0.34 0.35 0.37
    Pivot Point 0.34 0.34 0.33 0.34 0.34
    Support 1 (S1) 0.32 0.32 0.31 0.32 0.30
    Support 2 (S2) 0.31 0.32 0.31 0.30
    Support 3 (S3) 0.29 0.31 0.30
    Support 4 (S4) 0.29